FLEMING MEDICAL LIMITED

Company Registration Number:
08117103 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

FLEMING MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

FLEMING MEDICAL LIMITED

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 9,041 14,251
Investments:   0 0
Total fixed assets: 9,041 14,251
Current assets
Stocks: 0 0
Debtors:   232,603 260,266
Cash at bank and in hand: 713,801 850,025
Investments:   0 0
Total current assets: 946,404 1,110,291
Creditors: amounts falling due within one year:   (589,365) (827,465)
Net current assets (liabilities): 357,039 282,826
Total assets less current liabilities: 366,080 297,077
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 366,080 297,077
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 365,980 296,977
Shareholders funds: 366,080 297,077

The notes form part of these financial statements

FLEMING MEDICAL LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 May 2026
and signed on behalf of the board by:

Name: Mark Fleming
Status: Director

The notes form part of these financial statements

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 9 9

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 26,048
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2025 26,048
Depreciation
At 01 January 2025 11,797
Charge for year 5,210
On disposals 0
Other adjustments 0
At 31 December 2025 17,007
Net book value
At 31 December 2025 9,041
At 31 December 2024 14,251